Live Breaking News & Updates on Business Review Committee

Stay updated with breaking news from Business review committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder value

. ....

Chris Chapman , Michael Abecassis , Company Board Of Directors , Business Review Committee , Mymd Pharmaceuticals Inc , Drug Administration , Pharmacyte Biotech Inc , Pharmacyte Biotech , Cell Ina Box , Private Securities Litigation Reform Act ,

Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance

Revenue increased 9% to $54.9 billionGAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS increased. ....

United States , Erich Timmerman , Jason Hollar , Debbie Weitzman , Robert Bob Azelby , Michelle Greene , Matt Sims , Elliott International , Department Of Justice , Attributable To Cardinal Health Inc , Cardinal Health , Prnewswire Cardinal Health , Cardinal Health Us Medical Products , Cardinal Health Form , Specialty Networks , Specialty Solutions , Elliott Associates , America Most Innovative Companies , Precision Health Solutions , Cardinal Health Inc , Home Solutions , America Securities Health Care Conference , Global Medical Products , Medical Products , Fiscal Year , Chief Executive Officer ,

Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook

Revenue increased 12% to $57.4 billionGAAP1 operating earnings were $482 million; GAAP diluted EPS was $1.43Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS increased. ....

United States , Jason Hollar , Erich Timmerman , Matt Sims , Attributable To Cardinal Health Inc , Cardinal Health Form , Prnewswire Cardinal Health , Elliott International , Specialty Solutions , Cardinal Health Inc , Specialty Networks , Elliott Associates , Cardinal Health Brand , Home Solutions , Precision Health Solutions , Health Solutions , Cardinal Health , Association For The Advancement Of Medical Instrumentation , Department Of Justice , Medical Improvement Plan , Aaron Alt , Global Medical Products , Pharmaceutical Segment , Medical Segment , Segment Profit , Medical Improvement ,

Christopher Kubasik: L3Harris to Put Off M&A Program for 'Foreseeable Future'

Looking for the latest GovCon News? Check out our story: Christopher Kubasik: L3Harris to Put Off M&A Program for Foreseeable Future. Click to read more! ....

United States , Aerojet Rocketdyne , Christopher Kubasik , Business Review Committee , Govcon Wire , Daily Updates , News Briefings ,

L3Harris Technologies (LHX) Details Financial Objectives and Value Creation Strategy

L3Harris Technologies (LHX) Details Financial Objectives and Value Creation Strategy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Christophere Kubasik , Business Review Committee , Trusted Disruptor , Investor Relations ,